Trial · NCT07910084
Notification Of High-Risk Veterans for Access to Heart Failure Prevention
NCT07910084, Not applicable, Not yet recruiting, Palo Alto Veterans Institute for Research
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Notification Of High-Risk Veterans for Access to Heart Failure Prevention. Trials, record NCT07910084. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910084
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Notification Of High-Risk Veterans for Access to Heart Failure Prevention
- NCT number
- NCT07910084
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 250 participants, estimated
- Lead sponsor
- Palo Alto Veterans Institute for Research
- Conditions
- Heart Failure
- Interventions
- Notification and Cardiology Referral, Notification and Cardiology Referral Plus Care Navigation
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | New preventive treatments | 6 months | Number of preventive treatments initiated or intensified to address prespecified opportunities to reduce heart failure risk in the 6 months after trial enrollment |
| Secondary | Primary outcome by clinician type | 6 months | Number of preventive treatments initiated or intensified to address prespecified opportunities to reduce heart failure risk in the 6 months after trial enrollment by primary care versus cardiology providers |
| Secondary | Refill rates | 6 months | Proportion of new preventive medications prescribed that were refilled after the first prescription |
| Secondary | Blood pressure measurement | 6 months | Blood pressure recorded in the health record during the 6-month follow up period (yes/no) |
| Secondary | Change in systolic and diastolic blood pressure if elevated at baseline | 6 months | Average change in systolic and diastolic blood pressure among those with elevated blood pressure (\>130 mmHg systolic, \>80 mmHg diastolic) at baseline from baseline value to 6 months (most recent measurement carried forward at 6 months) |
| Secondary | New heart failure or reduced left ventricular ejection fraction | 6 months | New diagnoses of heart failure (defined as the presence of 2 ICD-10 codes for heart failure at outpatient or acute care visits) or newly reduced left ventricular ejection fraction (LVEF) \<50% on echocardiography |
| Secondary | Cardiology referrals | 6 months | Proportion of patients enrolled in the intervention arms with a signed cardiology referral |
| Secondary | Cardiology visits | 6 months | Proportion of patients in the intervention arms with signed cardiology referrals who complete at least one cardiology visit |
| Secondary | Care navigation opt-outs | 6 months | Proportion of patients in the care navigation arm opting out of care navigation contact |
| Secondary | Care navigator contact frequency | 6 months | Frequency of contacts by the care navigator with patients, average number of contacts per patient |
1 to 10 of 20Source ClinicalTrials.gov
See all 20 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910084
GET https://conductscience.org/api/trials/v1/NCT07910084/registered